Update on Immunohistochemistry for the Diagnosis of Lung Cancer

被引：106

作者：

Inamura, Kentaro ^{[1
]}

机构：

[1] Japanese Fdn Canc Res, Canc Inst, Div Pathol, Koto Ku, 3-8-31 Ariake, Tokyo 1358550, Japan

来源：

CANCERS | 2018年 / 10卷 / 03期

关键词：

immune checkpoint; immunostaining; INSM1; morphology; non-small cell lung carcinoma (NSCLC); pathology; thoracic tumor; small cell lung carcinoma (SCLC); tyrosine kinase; WHO classification; NUT MIDLINE CARCINOMA; GROWTH-FACTOR RECEPTOR; LIGAND; EXPRESSION; PREVIOUSLY TREATED PATIENTS; PD-L1; IMMUNOHISTOCHEMISTRY; CELL-CARCINOMA; OPEN-LABEL; ROS1; INTERNATIONAL-ASSOCIATION; BAP1;

D O I：

10.3390/cancers10030072

中图分类号：

R73 [肿瘤学];

学科分类号：

100214 ;

摘要：

Immunohistochemistry is a widely available technique that is less challenging and can provide clinically meaningful results quickly and cost-efficiently in comparison with other techniques. In addition, immunohistochemistry allows for the evaluation of cellular localization of proteins in the context of tumor structure. In an era of precision medicine, pathologists are required to classify lung cancer into specific subtypes and assess biomarkers relevant to molecular-targeted therapies. This review summarizes the hot topics of immunohistochemistry in lung cancer, including (i) adenocarcinoma vs squamous cell carcinoma; (ii) neuroendocrine markers; (iii) ALK, ROS1, and EGFR; (iv) PD-L1 (CD274); (v) lung carcinoma vs malignant mesothelioma; and (vi) NUT carcinoma. Major pitfalls in evaluating immunohistochemical results are also described.

引用

页数：15

共 108 条

[81] Clinical Features and Outcome of Patients With Non-Small-Cell Lung Cancer Who Harbor EML4-ALK [J].

Shaw, Alice T. ;

Yeap, Beow Y. ;

Mino-Kenudson, Mari ;

Digumarthy, Subba R. ;

Costa, Daniel B. ;

Heist, Rebecca S. ;

Solomon, Benjamin ;

Stubbs, Hannah ;

Admane, Sonal ;

McDermott, Ultan ;

Settleman, Jeffrey ;

Kobayashi, Susumu ;

Mark, Eugene J. ;

Rodig, Scott J. ;

Chirieac, Lucian R. ;

Kwak, Eunice L. ;

Lynch, Thomas J. ;

Iafrate, A. John .

JOURNAL OF CLINICAL ONCOLOGY, 2009, 27 (26) :4247-4253

[82] Clinical and biological features associated with epidermal growth factor receptor gene mutations in lung cancers [J].

Shigematsu, H ;

Lin, L ;

Takahashi, T ;

Nomura, M ;

Suzuki, M ;

Wistuba, II ;

Fong, KM ;

Lee, H ;

Toyooka, S ;

Shimizu, N ;

Fujisawa, T ;

Feng, ZD ;

Roth, JA ;

Herz, J ;

Minna, JD ;

Gazdar, AF .

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE, 2005, 97 (05) :339-346

[83] Primary Pulmonary NUT Midline Carcinoma [J].

Sholl, Lynette M. ;

Nishino, Mizuki ;

Pokharel, Saraswati ;

Mino-Kenudson, Mari ;

French, Christopher A. ;

Janne, Pasi A. ;

Lathan, Christopher .

JOURNAL OF THORACIC ONCOLOGY, 2015, 10 (06) :951-959

[84]

Sholl LM, 2013, AM J SURG PATHOL, V37, P1441, DOI 10.1097/PAS.0b013e3182960fa7

[85] PD-1 expression on tumor-specific T cells: Friend or foe for immunotherapy? [J].

Simon, Sylvain ;

Labarriere, Nathalie .

ONCOIMMUNOLOGY, 2018, 7 (01)

[86] Identification of the transforming EML4-ALK fusion gene in non-small-cell lung cancer [J].

Soda, Manabu ;

Choi, Young Lim ;

Enomoto, Munehiro ;

Takada, Shuji ;

Yamashita, Yoshihiro ;

Ishikawa, Shunpei ;

Fujiwara, Shin-ichiro ;

Watanabe, Hideki ;

Kurashina, Kentaro ;

Hatanaka, Hisashi ;

Bando, Masashi ;

Ohno, Shoji ;

Ishikawa, Yuichi ;

Aburatani, Hiroyuki ;

Niki, Toshiro ;

Sohara, Yasunori ;

Sugiyama, Yukihiko ;

Mano, Hiroyuki .

NATURE, 2007, 448 (7153) :561-U3

[87]

Solomon BJ, 2014, NEW ENGL J MED, V371, P2167, DOI [10.1056/NEJMoa1408440, 10.1056/NEJMx150034]

[88] BET Proteins as Targets for Anticancer Treatment [J].

Stathis, Anastasios ;

Bertoni, Francesco .

CANCER DISCOVERY, 2018, 8 (01) :24-36

[89] Clinical Response of Carcinomas Harboring the BRD4-NUT Oncoprotein to the Targeted Bromodomain Inhibitor OTX015/MK-8628 [J].

Stathis, Anastasios ;

Zucca, Emanuele ;

Bekradda, Mohamed ;

Gomez-Roca, Carlos ;

Delord, Jean-Pierre ;

Rouge, Thibault de La Motte ;

Uro-Coste, Emmanuelle ;

de Braud, Filippo ;

Pelosi, Giuseppe ;

French, Christopher A. .

CANCER DISCOVERY, 2016, 6 (05) :492-500

[90] The association between PD-L1 and EGFR status and the prognostic value of PD-L1 in advanced non-small cell lung cancer patients treated with EGFR-TKIs [J].

Tang, Yanna ;

Fang, Wenfeng ;

Zhang, Yaxiong ;

Hong, Shaodong ;

Kang, Shiyang ;

Yan, Yue ;

Chen, Nan ;

Zhan, Jianhua ;

He, Xiaobo ;

Qin, Tao ;

Li, Ge ;

Tang, Wenyi ;

Peng, Peijian ;

Zhang, Li .

ONCOTARGET, 2015, 6 (16) :14209-14219

← 2 3 4 5 6 7 8 9 10 11 →